• Health & Medicine

Immune-stimulating injection turns tumours into ‘cancer vaccine factories’ in mice

Injecting immune cell stimulants directly into a tumour could help the immune system spot and attack cancer cells, according to new research in mice. Injecting immune cell stimulants directly into a tumour could help the immune system spot and attack cancer cells, according to new research in mice.

8 April 2019

• Health & Medicine

Kidney cancer immunotherapy combo approved for NHS use in England

A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England. A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England.

5 April 2019

• Health & Medicine

Lung cancer immunotherapy approved for NHS patients in England

An immunotherapy drug will be made available on the NHS in England for certain people with lung cancer. An immunotherapy drug will be made available on the NHS in England for certain people with lung cancer.

28 March 2019

• Health & Medicine

CAR T cell immunotherapy for lymphoma rejected in Scotland

Patients living with an aggressive form of lymphoma in Scotland will not get access to a new immunotherapy treatment after it was rejected for use on the NHS. Patients living with an aggressive form of lymphoma in Scotland will not get access to a new immunotherapy treatment after it was rejected for use on the NHS.

13 March 2019

• Health & Medicine

Leukaemia drug gets initial ‘no’ for NHS in England

Patients with a specific type of leukaemia will not have access to a new treatment after it failed to win provisional recommendation for NHS use in England. Patients with a specific type of leukaemia will not have access to a new treatment after it failed to win provisional recommendation for NHS use in England.

6 March 2019

• Health & Medicine

Drug combination boosts kidney cancer survival in trials

Combining a targeted cancer drug with an immunotherapy extends the lives of advanced kidney cancer patients, according to two clinical trials. Combining a targeted cancer drug with an immunotherapy extends the lives of advanced kidney cancer patients, according to two clinical trials.

19 February 2019

• Health & Medicine

Double NHS decision for CAR T cell immunotherapy in Scotland

Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer. Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer.

13 February 2019

• Health & Medicine

First patient receives CAR T cell therapy on NHS

An 11-year-old boy became the first NHS patient to receive a personalised blood cancer immunotherapy on the NHS. An 11-year-old boy became the first NHS patient to receive a personalised blood cancer immunotherapy on the NHS.

31 January 2019

• Health & Medicine

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England. People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

13 December 2018

• Health & Medicine

Immunotherapy drug made available for some NHS patients with advanced skin cancer after surgery

An immunotherapy drug will be made available to some patients with advanced melanoma skin cancer on the NHS in England. An immunotherapy drug will be made available to some patients with advanced melanoma skin cancer on the NHS in England.

30 November 2018

• Health & Medicine

Immunotherapy drug to be made available for some NHS patients with advanced skin cancer

Some patients with advanced skin cancer will now have access to immunotherapy after surgery on the NHS in England. Some patients with advanced skin cancer will now have access to immunotherapy after surgery on the NHS in England.

21 November 2018